Drug Development
Containing Coronavirus Through Innovation and Investment: An Xconomy Special Report
This report contains ideas, innovation, and experience from some of the major players at the forefront of efforts in combatting COVID-19. The exclusive articles were captured from the BIO-Europe SpringĀ® event and are accompanied by some of the most pertinent stories from B2B publications Xconomy and Bioprocess Insider.
Information inside this special report includes:
- How Regeneron, Moderna and J&J are helping to battle Covid ā 19
- Funding for Coronavirus R&D ā government and private sector involvement
- How investors shaken by Coronavirus sow seeds of M&A
- Lessons learned by Chinese leaders
